Committee Composition



  Audit Compensation Nominating and Governance
Michael O. Johnson Chairman of the Board      
Richard P. Bermingham Committee Chair for Audit Committee Member of Compensation Committee  
Richard H. Carmona     Committee Chair for Nominating and Governance Committee
Richard Carmona Director

Dr. Carmona has been Vice Chairman of Canyon Ranch, a life-enhancement company, since October 2006. He also serves as Chief Executive Officer of the Canyon Ranch Health division and president of the nonprofit Canyon Ranch Institute. He is also the first Distinguished Professor of Public Health at the Mel and Enid Zuckerman College of Public Health at the University of Arizona. Prior to joining Canyon Ranch, Dr. Carmona served as the 17th Surgeon General of the United States from August 2002 through July 2006. Previously, he was Chairman of the State of Arizona Southern Regional Emergency Medical System; a professor of surgery, public health, and family and community medicine at the University of Arizona; and surgeon and deputy sheriff of the Pima County, Arizona, Sheriff’s Department. Dr. Carmona served in the U.S. Army and the Army’s Special Forces. Dr. Carmona is a director of Taser International Inc. and the Clorox Company.


Jonathan Christodoro   Member of Compensation Committee Member of Nominating and Governance Committee
Jeffrey T. Dunn  L     Member of Nominating and Governance Committee
Hunter C. Gary   Member of Compensation Committee  
Jesse A. Lynn     Member of Nominating and Governance Committee
Michael Montelongo Member of Audit Committee    
James L. Nelson Member of Audit Committee    
Maria Otero   Committee Chair for Compensation Committee  
Chair of the Board = Chair of the Board Committee Chair = Chair Committee Member = Member    L = Lead Independant Director

Stock transaction information provided by EDGAR Online. Herbalife Ltd. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Events

View all »Events & Presentations

Nov 2, 2017
Q3 2017 Herbalife Ltd. Earnings Conference Call
Webcast Listen to webcast
PDF Q3 2017 Herbalife Ltd. Earnings Transcript   92.9 KB   Add to Briefcase

Aug 1, 2017
Q2 2017 Herbalife Ltd. Earnings Conference Call
Webcast Listen to webcast
PDF Q2 2017 Herbalife Ltd. Earnings Transcript  178.6 KB   Add to Briefcase

May 23, 2017
Herbalife Investor Presentation May 2017
PDF View Presentation   1.7 MB   Add to Briefcase


Stock Information

Price:
70.05
Change:
0.00
Day High:
N/A
Day Low:
N/A
Volume:
N/A
4:02 PM ET on Dec 14, 2017
Delayed at least 20 minutes.
Provided by eSignal.

Quarterly Supplements


Non GAAP Financial Measures

PDF NonGAAP measures - Net Debt Adjusted Operating Income and Adjusted EPS

PDF NonGAAP measures - SGA and Adjusted SGA

PDF NonGAAP measures - FX Adjusted P&L

PDF NonGAAP measures - EBITDA and Adjusted EBITDA

PDF NonGAAP measures - Contribution Margin for Certain Markets


Other Measures

PDF Quarterly Breakout Key Metrics